Concurrent Surgery for Locoregional Gynecologic Cancers and Pelvic Floor Disorders in a Population of Patients With Medicare Insurance. Issue 4 (9th April 2023)

• Record Type: Journal Article
• Authors: Corey, Logan; Seaton, Randell; Ruterbusch, Julie J.; Bretschneider, Carol Emi; Vezina, Alex; Do, Trieu; Hobson, Deslyn; Winer, Ira
• Is Part Of: Obstetrics and gynecology. Volume 141:Issue 4(2023)
• Page Start: 629
• Page End: 641
• Publication Date: 2023-04-09
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; 618
• DOI: 10.1097/AOG.0000000000005085
• Languages: English
• ISSNs: 0029-7844

Abstract

Abstract : The rate of concurrent surgery for early-stage gynecologic cancer and pelvic floor disorders is higher than previously thought but still represents a potential missed opportunity for treatment. Abstract : OBJECTIVE: To estimate the rate of concurrent surgery for locoregional gynecologic cancer and pelvic organ prolapse–urinary incontinence (POP–UI) and to assess the rate of surgery for POP–UI within 5 years for those who did not undergo concurrent surgery. METHODS: This is a retrospective cohort study. The SEER-Medicare data set was used to identify cases of local or regional endometrial, cervical, and ovarian cancer diagnosed from 2000 to 2017. Patients were followed up for 5 years from diagnosis. We used χ 2 tests to identify categorical variables associated with having a concurrent POP–UI procedure with hysterectomy or within 5 years of hysterectomy. Logistic regression was used to calculate odds ratios and 95% CIs adjusted for variables statistically significant (α=.05) in the univariate analyses. RESULTS: Of 30, 862 patients with locoregional gynecologic cancer, only 5.5% underwent concurrent POP–UI surgery. Of those with a preexisting diagnosis related to POP–UI, however, 21.1% had concurrent surgery. Of the patients who had a diagnosis of POP–UI at the time of initial surgery for cancer and who did not undergo concurrent surgery, an additional 5.5% had a second surgery for POP–UI within 5 years. The rate of concurrent surgery remained constant over the time period (5.7% in 2000 and 2017) despite an increase in the frequency of POP–UI diagnosis in the same time frame. CONCLUSION: The rate of concurrent surgery for patients with an early-stage gynecologic cancer and POP–UI–associated diagnosis in women older than age 65 years was 21.1%. Of women who did not undergo concurrent surgery but had a diagnosis of POP–UI, 1 in 18 underwent surgery for POP–UI within 5 years of their index cancer surgery. Dedicated efforts must be made to identify patients who would most benefit from concurrent cancer and POP–UI surgery in those with locoregional gynecologic cancers and pelvic floor disorders.